SANOFI pulls leukaemia drug CAMPATH ($76 million last year) to clear way for higher-priced MS-drug called LEMTRADA (Alemtuzumab), which is expected to grow to $400+ million by 2018. http://www.reuters.com/article/2012/08/20/us-sanofi-drug-idUSBRE87J0KB20120820

To get this deal smoothly & profitable done at first SANOFI had to get rid of CAMPATH (already has been withdrawn in some European countries) to command a HIGHER PRICE for much LOWER MS-doses and to prevent a cheaper off-label use of Campath in MS-cash-cows.

But who is working behind the scene on this Multi-Million-$$$-MS-drug-deal?

Surprise, surprise – The same people who are working there are trying to prevent research in CCSVI as well!

- Prof Alastair Compston, Head of Department of Clinical Neurosciences, Cambridge who has been heavily involved in this cancer drug and who is working tirelessly to launch it, better to speak to recycle this drug to abuse all the “MS” victims furthermore. http://www.businesswire.com/news/home/20111113005072/en/Genzyme-Announces-

- Dr. Alasdair Coles, Neuroimmunologist, Cambridge and one of the chief marketing people for LEMTRADA who acted at the same time as MS Society's adviser to the NICE Consultation on CCSVI in the UK! He was (allegedly) asked THREE times if he had any interests to declare but (allegedly) he said THREE times that he had no conflicts of interest to declare.  ---- Perhaps it’s time to call the police now??? ----

Get more information about the so called scientists who supposedly want cure “MS”  http://www.facebook.com/photo.php?fbid=3956291984150&set=a.3664619772527.2162924.1185729368&type=1&theater and who are very worried at the same time as well that too many of us will read this book - "Multiple Sclerosis - the image and its message" by Dr. Franz Schelling: http://www.ms-info.net/ms_040504.pdf.